<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Immunovant Inc</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Fri, 17 Apr 2026 22:14:55 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>IMVT 21.89$ (-49%)</title>
<link>http://www.aktiencheck.de/forum/IMVT_21_89_49-A2P5G1-t573667</link>
<guid>http://www.aktiencheck.de/forum/IMVT_21_89_49-A2P5G1-t573667</guid>
<description>IMVT $40 / +100%, https://www.marketscreener.com/quote/stock/IMMUNOVANT-INC-60342551/news/Immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-44922041/

Damit innerhalb eines Jahres von 5 auf 40 !

(Schade, habe mich mehr mit der Mutter, Roivant, befasst. [&lt;a href=&#034;http://www.aktiencheck.de/forum/IMVT_21_89_49-A2P5G1-t573667&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







